These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 1185526)
21. Letter: Legalization of laetrile--a suggestion. Crile G N Engl J Med; 1976 Jul; 295(2):116. PubMed ID: 1272319 [No Abstract] [Full Text] [Related]
22. Over-the-counter human drugs; labeling requirements; final rule; technical amendment. Food and Drug Administration, HHS. Final rule; technical amendment. Fed Regist; 2000 Jan; 65(1):7-9. PubMed ID: 11010625 [TBL] [Abstract][Full Text] [Related]
23. Human and veterinary drugs: good manufacturing practices and proposed exemptions for certain OTC products. Fed Regist; 1978 Sep; 43(190 Pt 2):45013-89. PubMed ID: 10316700 [No Abstract] [Full Text] [Related]
24. The debate continues on OTC switches. Giaquinta D Manag Care Interface; 2003 Jun; 16(6):49-50. PubMed ID: 12841076 [No Abstract] [Full Text] [Related]
25. The Food and Drug Administration's over-the-counter drug review: why review OTC drugs? Moxley JH; Yingling GL; Edwards CC Fed Proc; 1973 Apr; 32(4):1435-7. PubMed ID: 4701750 [No Abstract] [Full Text] [Related]
26. Sunscreen update. Barker MO Am J Contact Dermat; 1997 Dec; 8(4):247-9. PubMed ID: 9358121 [No Abstract] [Full Text] [Related]
27. An update on the therapeutic orphan. Wilson JT Pediatrics; 1999 Sep; 104(3 Pt 2):585-90. PubMed ID: 10469794 [No Abstract] [Full Text] [Related]
28. Is three a crowd or company?: Behind-the-counter drugs. Barth AS Food Drug Law J; 2008; 63(4):865-89. PubMed ID: 19601386 [No Abstract] [Full Text] [Related]
29. Laetrile and liberty. Zimmerly JG Leg Aspects Med Pract; 1978 Oct; 6(10):10. PubMed ID: 750806 [No Abstract] [Full Text] [Related]
30. Primary prevention with over-the-counter statins: a cautionary tale. Davidoff F Clin Pharmacol Ther; 2005 Sep; 78(3):218-20. PubMed ID: 16153392 [No Abstract] [Full Text] [Related]
31. Against legalization of laetrile. Baker JJ; Lokey JL; Price NA; Watkins WL; Winokur SH N Engl J Med; 1976 Sep; 295(12):679. PubMed ID: 972654 [No Abstract] [Full Text] [Related]
32. Editorial: To cough or not to cough. J Am Osteopath Assoc; 1973 Dec; 73(4):268-70. PubMed ID: 4491950 [No Abstract] [Full Text] [Related]
34. Laetrile: Canada's legal position firm but pressure in the South grows. Gray C Can Med Assoc J; 1977 Nov; 117(9):1068-74. PubMed ID: 912631 [No Abstract] [Full Text] [Related]
35. The cosmetic/drug dilemma: FDA regulation of alpha-hydroxy acids. Heymann LA Food Drug Law J; 1997; 52(4):357-75. PubMed ID: 10346670 [No Abstract] [Full Text] [Related]
36. Editorial: Safe and sane use of OTC's. Tice LF Am J Pharm Sci Support Public Health; 1973; 145(6):187-8. PubMed ID: 4768815 [No Abstract] [Full Text] [Related]
37. Drug marketing exclusivity under United States and European Union law. Junod V Food Drug Law J; 2004; 59(4):479-518. PubMed ID: 15875347 [No Abstract] [Full Text] [Related]
38. Editorial: Dr. Jekyll and Mr. Hyde. Feldmann EG J Pharm Sci; 1974 Mar; 63(3):1. PubMed ID: 4820358 [No Abstract] [Full Text] [Related]
39. James Harvey Young, PhD, (1915-2006). Historian of medical quackery. Marcus DM Pharos Alpha Omega Alpha Honor Med Soc; 2008; 71(3):16-21. PubMed ID: 18767597 [No Abstract] [Full Text] [Related]
40. Editorial: Megavitamin this and megavitamin that. White PL JAMA; 1975 Aug; 233(6):538-9. PubMed ID: 1173669 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]